Accord Healthcare Recalls Carmustine Due to Out of Specification Test Result
Accord Healthcare is recalling a batch of Carmustine 100 mg due to an out of specification test result.
Asset / Drug
Drug and asset intelligence for Carmustine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Chemotherapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.